Understanding
Post-Transplant Lymphoproliferative Disease

Homepage Hero Image

What is PTLD and what does it mean for me? 

Post-transplant lymphoproliferative disease (PTLD) is a rare, but well-known complication of solid organ transplants and haematopoietic stem cell transplantation.1 PTLD is related to the Epstein-Barr virus and immunosuppression therapy.2 People who receive such transplants are subsequently treated with medication that suppresses their immune system.3

How does PTLD occur?

Post-transplant lymphoproliferative disorder (PTLD) is a type of cancer that can develop after a haematopoietic stem cell transplantation (also known as a bone marrow transplant) or after a solid organ transplant.

PTLD is a rare disease.

PTLD is considered a rare disease (i.e. occuring less that 1 in 2,000 patients, based on the official definition of rare disease of the European Union4) which occurs in a small percentage of transplant patients.

PTLD outlook.

Although PTLD can often be successfully treated when diagnosed early5, the disorder can place an additional medical and psychological burden on transplant patients due to its rapid progression.

Immunosuppression.

The compatibility between the donor and the patient, particularly in stem cell transplantation, is an important aspect because it affects the levels of immunosuppression required.

PTLD and EBV.

PTLD is sometimes associated with Epstein-Barr virus (EBV) infection. EBV is a common herpes virus that does not usually cause problems in people with standard immune systems. In immunosuppressed post-transplant patients, however, EBV infection may remain uncontrolled and eventually lead to PTLD.6

Effects of EBV.

PTLD can be caused by reactivation of the patient's EBV or by reactivation of the donor's EBV.7 This causes uncontrolled growth of cells in the patient's lymph nodes and other organs, which can lead to the development of cancer.

Support

Find PTLD patient support near you

Use the interactive map to find relevant PTLD patient group support organisations in your country.

Locations

Germany

Germany

Leukämiehilfe RHEIN-MAIN e.V

Germany, Ruesselsheim
 

Website: https://www.leukaemiehilfe-rhein-main.de 

Email: buero@lhrm.de

Phone: +49 (0) 6142-32240

Portugal

Portugal

Associação Portuguesa de Insuficientes Renais

Portugal, Lisbon

Website link: http://www.apir.org.pt/

Email: apir@apir.org.pt

Phone: +351 218 371 654

Spain

Spain

Asociación Española de Ayuda a Niños, Adultos y Familias con Fallo Intestinal, Nutrición Parenteral y Trasplante Multivisceral

Spain, Madrid

Website: www.somosnupa.org

Email: ayuda@somosnupa.org, comunicacion@somosnupa.org

Telephone: +34 91 022 58 38

Spain

Spain

Federación Nacional de Enfermos y Trasplantados Hepáticos

Spain, Madrid

Website: www.fneth.org

Email: secretaria@fneth.org

Phone:  +34917 396 872

Poland

Poland

Alivia Cancer Foundation

Poland, Warsaw

Website: www.alivia.org.pl

Email: info@alivia.org.pl

Phone: +48  22 266 03 40

Europe

Europe

Website: https://ekpf.eu

Email: info@ekpf.eu

Telephone number +34915610837 (Administrative Office – SPAIN)

Italy

Italy

Unione Trapiantati Polmone - Padova ODV

Italia, Padova
 

Website: www.oltrelamalattia.it 

Email: info@oltrelamalattia.it

Phone: +39 3494411887

France

France

Ensemble Leucemie Lymphomes Espoir

France, Paris

Website: www.ellye.fr

Email: infos@ellye.fr

Phone: +33 01 42 38 54 66

Patient resources

Learn more about PTLD

Explore tools and resources to help understand PTLD.

This website is developed and fully funded by:

Sponsored By

This website is intended for patients and carers within the European Union.

HQ--11-23-2300001 Date of elaboration: March 2024 

Privacy Policy.